Fresenius Medical Care (FMS) stock gains as parent Fresenius SE (FSNUF) (FSNUY) cuts its stake to ~20% from ~25%. Read more here.
The Care Quality Commission rates Scarborough dialysis unit inadequate after finding failings.
Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.
Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.
Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.
Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.
Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.
FMS' transformation is lifting profitability, while HDF, value-based care and cost savings offset volume and reimbursement pressures.
BAD HOMBURG, Germany, Oct. 7, 2026/ PRNewswire/-- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced that Shervin J. Korangy will become Chief Executive Officer and Chair of the Management Board, effective October 12, 2026. The Supervisory Board unanimously appointed him to succeed...
Fresenius Medical Care is improving operationally, with Q2 2026 organic revenue up 5% and adjusted operating profit up 23%. Read why FMS stock is a hold.
FMS refines its China strategy around advanced dialysis and critical-care technologies, with 110M euros in one-time costs.
Fresenius Medical Care updates China strategy, and incurs a 110 million euro charge while focusing on advanced dialysis tech.
Fresenius Medical Care (FMS) said Friday it has refined its China commercial strategy, with plans to
The U.S. Food and Drug Administration (FDA) on Tuesday issued a warning letter to Fresenius Medical Care AG & Co. KGaA’s Fresenius USA Manufacturing following a March 2026 inspection at its Ogden, Utah production facility. In a letter to the...
Fresenius Medical is scaling its 5008X rollout across U.S. clinics, creating growth potential despite volume, reimbursement and rollout-cost pressures.
Fresenius Medical's improving profitability, 5008X rollout and value-based care gains offer support despite volume and reimbursement risks.
This is the newest page. Registered accounts read further back.